For contract drug manufacturers with global aspirations, establishing a presence in both the U.S. and abroad is an increasingly common goal. That’s certainly the story for U.K.-based Sterling Pharma, which is fleshing out its stateside offerings with the purchase of an established ingredients plant.
Sterling has acquired Alcami’s former active pharmaceutical ingredient (API) plant in Germantown, Wisconsin, as the company aims to beef up in the U.S., Sterling said Wednesday.
Sterling’s Germantown buyout is the small-molecule API maker’s latest move in an investment drive worth $46 million over the last four years, Sterling said in a release. The plant will come with “specialist expertise” in technologies that include cryogenic reactions and plant-scale hydrogenation or the process of adding molecular hydrogen to another compound.
Whitepaper
Developing COVID-19 vaccines may not be enough: Turning vaccines into vaccinations
COVID-19 vaccines are being developed at a breakneck pace, but a broken supply chain could derail that momentum. What are the steps needed to help ensure the medical supply chain is up to the task?
A Sterling spokesperson could not be reached for comment by press time.
twisted family secrets full movie limpiando culo snigdha sinha video anyxvideos.com sex slave full video view here ksb besaba com katrina reyal sex garden on house wife rape 1st sex young xnxx-br.com bd bdsexvideo sasur bhou sex romance bluepornsex video xxx vide0 gan czech teen swallow money گایدن افقانی anushka sharma ki video vdeo xxx japaeb fetishwife clare